Russell C Hirsch insider trades: Vitae Pharmaceuticals (VTAE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Russell reports to the SEC
and 3 more companies
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 29, 2014 | VTAE | ↑ Buy | 671,807 | $8.00 | $5.4M | Indirect | Oct 1, 2014 (2d) |
| May 31, 2013 | BAXS | ↑ Buy | 2,009,806 | $2.28 | $4.6M | Prospect Venture Partners III, L.P. | Jun 4, 2013 (4d) |
| Dec 2, 2010 | AVEO | ↓ Sell | 317,572 | $14.93 | $4.7M | By Prospect Venture Partners II, L.P. | Dec 3, 2010 (1d) |
| Dec 2, 2010 | AVEO | ↓ Sell | 4,836 | $14.93 | $72K | By Prospect Associates II, L.P. | Dec 3, 2010 (1d) |
| Apr 21, 2010 | HNSN | ↑ Buy | 123,125 | $2.00 | $246K | By Prospect Venture Partners II, L.P. | Apr 23, 2010 (2d) |
| Apr 21, 2010 | HNSN | ↑ Buy | 1,875 | $2.00 | $4K | By Prospect Associates II, L.P. | Apr 23, 2010 (2d) |
| Apr 22, 2009 | HNSN | ↑ Buy | 303,078 | $3.25 | $985K | By Prospect Venture Partners II, L.P. | Apr 22, 2009 (0d) |
| Apr 22, 2009 | HNSN | ↑ Buy | 4,615 | $3.25 | $15K | By Prospect Associates II, L.P. | Apr 22, 2009 (0d) |
| Jun 5, 2007 | FOLD | ↓ Sell | 6,330 | $15.00 | $95K | By Prospect Venture Partners II, L.P. | Jun 6, 2007 (1d) |
| Jun 5, 2007 | FOLD | ↓ Sell | 97 | $15.00 | $1K | By Prospect Associates II, L.P. | Jun 6, 2007 (1d) |
| Oct 17, 2006 | TRBN | ↑ Buy | 34,653 | $13.00 | $450K | By Prospect Venture Partners II, L.P. | Oct 19, 2006 (2d) |
| Oct 17, 2006 | TRBN | ↑ Buy | 528 | $13.00 | $7K | By Prospect Associates II, L.P. | Oct 19, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Russell C Hirsch's insider trades
Russell C Hirsch is a 10% owner of Vitae Pharmaceuticals (VTAE). Since Oct 17, 2006, Russell has reported 8 open-market purchases worth $11.7M and 4 sales worth $4.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (8 filings), conversions (8 filings), grants and awards (8 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VTAE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.